Open
Actively Recruiting
Use of Acthar in Rheumatoid Arthritis (RA) Related Flares
About
Brief Summary
This is a Rheumatoid Arthritis (RA) study. The purpose of this research study is to determine in RA flare, whether musculoskeletal ultrasound (MSUS) inflammatory scores and/or disease activity scores improve with Acthar treatment.
Primary Purpose
Study Type
Phase
Eligibility
Gender
Healthy Volunteers
Minimum Age
Maximum Age
Inclusion Criteria:
- Patient must meet 1987 ACR criteria
- Age > 18 years of age
- Baseline DAS28/Erythrocyte Sedimentation Rate (ESR) >=3.2
- Stable concomitant Disease Modifying Anti-Rheumatic Drugs (DMARDs)
- Stable prednisone <10mg or equivalent
- Power Doppler score of >=10
Exclusion Criteria:
- Prior treatment with Acthar in the past 2mos
- Meet one of the above RA flare requirements
- Subjects who have received live or live attenuated vaccines within 6 weeks prior to the first dose of study drug (or the zoster vaccine)
Join this Trial
Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
15-001199
Category
Autoimmune Disorders
Principal Investigator
Contact
Location
- UCLA Westwood